Ivan Felix Lee

US Patent:

20170289087, Oct 5, 2017

Filed:

Nov 14, 2013

Appl. No.:

14/080781

Inventors:

- Mountain View CA, US
Balaji Srinivasan - Saratoga CA, US
Ivan Lee - Mountain View CA, US
Joshua Oldmeadow - Sunnyvale CA, US
Thomas R. Karlo - San Francisco CA, US
Francesco Nerieri - Santa Cruz CA, US
Daniel R. Sandler - Burlington MA, US
Xiaoyong Liu - Clyde Hill WA, US
Peter H. Williamson - Kirkland WA, US

Assignee:

Google Inc. - Mountain View CA

International Classification:

H04L 12/58

Abstract:

Systems, methods and computer readable media for delivery of notifications to devices without appropriate applications installed are disclosed. In some implementations, the systems, methods and computer readable media can deliver a notification message and process a response via an alternate mode when an appropriate application is not installed.

US Patent:

20050032804, Feb 10, 2005

Filed:

Jun 23, 2004

Appl. No.:

10/874992

Inventors:

Stephen Cypes - Santa Clara CA, US
Alex Chen - Metuchen NJ, US
Russell Ferlita - Westfield NJ, US
Karl Hansen - Atlantic Highlands NJ, US
Ivan Lee - Piscataway NJ, US
Vicky Vydra - Fair Lawn NJ, US
Robert Wenslow - East Windsor NJ, US

International Classification:

A61K031/498
C07D487/04

US Classification:

514249000, 544350000

Abstract:

The dihydrogenphosphate salt of 4-oxo-4-[3-(trifluoromethyl)-5,6-dihydro [1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]-1-(2,4,5-trifluorophenyl)butan-2-amine is a potent inhibitor of dipeptidyl peptidase-IV and is useful for the prevention and/or treatment of non-insulin dependent diabetes mellitus, also referred to as type 2 diabetes. The invention also relates to a crystalline monohydrate of the dihydrogenphosphate salt as well as a process for its preparation, pharmaceutical compositions containing this novel form and methods of use for the treatment of diabetes, obesity, and high blood pressure.